CN1219421A - Medicine for curing chronic bacterial prostatitis - Google Patents

Medicine for curing chronic bacterial prostatitis Download PDF

Info

Publication number
CN1219421A
CN1219421A CN 98123563 CN98123563A CN1219421A CN 1219421 A CN1219421 A CN 1219421A CN 98123563 CN98123563 CN 98123563 CN 98123563 A CN98123563 A CN 98123563A CN 1219421 A CN1219421 A CN 1219421A
Authority
CN
China
Prior art keywords
radix
medicine
chronic bacterial
bacterial prostatitis
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 98123563
Other languages
Chinese (zh)
Inventor
尧力畅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 98123563 priority Critical patent/CN1219421A/en
Publication of CN1219421A publication Critical patent/CN1219421A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A medicine for curing chronic bacterial prostatitis is prepared from 12 Chinese-medicinal materials such as honeysuckle flower, viola herb, anemarrhena rhizome and phellodendron bark, supplemented with Chinese angelica root, red sage root, dipsacus root, etc,and features high cure rate and no toxic by-effect.

Description

The medicine of treatment chronic bacterial prostatitis
The present invention relates to a kind of medicine for the treatment of chronic bacterial prostatitis, relate to a kind of pure Chinese herbal medicine that chronic, bacillary and nonspecific prostatitis is had very high curative effect specifically.
At present, the medicine that is applied to the clinical treatment chronic prostatitis generally has: trimethoprim (TMP), bactrim, erythromycin, lincomycin, rifampicin etc., also have: norfloxacin, ofloxacin, minocycline etc., these good medicines that stress results theoretically, actual efficacy is dissatisfied.Such as one group of patients with chronic prostatitis that continues to treat in 12 weeks with trimethoprim (TMP) or bactrim, only 1/3 obtain to cure, its reason is because the partial acid-base value of prostatitis patient changes and influenced penetrating and therapeutical effect of medicine.Therefore, no matter be to take medicine, have an injection, or vein splash into or fill in the anus medication, curative effect is all undesirable.Medicines such as domestic QIANLIEKANG commonly used, peace dysurea, its pharmacological action can not be affirmed.QIANLIEKANG is pure Pollen Preparations, the peace dysurea contains several amino acids, can play the effect that reduces prostatic edema, these two kinds of medicines are harmless to the human body beneficial, can play the effect of placebo, plant medicine such as South Africa this plant of star flowers and plants in addition, folium urticae and root, Semen Cucurbitae, Cortex Populi dividianae etc., prostatic hyperplasia there is certain curative effect, the proscar medicine of using clinically can obviously reduce the concentration of intraprostatic dihydrotestosterone recently, reduce prostatic hyperplasia, but this medicine costs an arm and a leg, need Time of Administration long, extensive use is restricted.Medicine does not in sum have tangible curative effect to chronic bacterial prostatitis, awaits further discussion.
The inventor according to clinical practice for many years think wet, hot, lose, the stasis of blood is prostatitic main pathological factor, chronic prostatitis is many by retention of damp-heat in the interior, due to the deficiency of the kidney, the essence of wherein suffering from a deficiency of the kidney is closed solid for falling ill originally, damp-heat in lower-JIAO pents up the mark for morbidity, and it is how in the majority with the deficiency of kidney yin person to suffer from a deficiency of the kidney.Damp and hot, suffer from a deficiency of the kidney that the two is often held under the arm mutually and be to suffer from reciprocal causation.Cloudy smart, kidney qi loss wet, the turbid stasis of blood of water occurs and stops, and holds in the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels; Weaken body's immunity, damp and hot heresy is taken advantage of empty invasion or is made damp and hot staying in the body and do not go.Damp and hotly increase the weight of to suffer from a deficiency of the kidney or congestion, make state of an illness process more intricate, this is the key factor that the primary disease difficulty heals.So many be the treatment rule, and develop new medicine with " heat-clearing and toxic substances removing, resolving turbidity and eliminating dampness are main, blood circulation promoting and blood stasis dispelling, tonifying liver kidney tonifying, raise immunity is auxilliary ".
The object of the present invention is to provide and a kind ofly make, can treat the medicine of chronic bacterial prostatitis by pure Chinese herbal medicine.
The object of the present invention is achieved like this, it is a principal agent by Flos Lonicerae, Herba Violae, living Radix Glycyrrhizae, the Rhizoma Anemarrhenae, Cortex Phellodendri mainly, pair is prepared from pure Chinese herbal medicine such as Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Radix Dipsaci, Radix Paeoniae Rubra, Radix Curcumae, Radix Rehmanniae, the Radix Paeoniae Albas, and it is characterized in that: it is the medicine that is prepared from by following weight percentages:
Flos Lonicerae 8-12% Herba Violae 8-12%
Give birth to Radix Glycyrrhizae 5-7% Rhizoma Anemarrhenae 6-10%
Cortex Phellodendri 6-10% Radix Angelicae Sinensis 6-9%
Radix Salviae Miltiorrhizae 7-12% Radix Dipsaci 6-10%
Radix Paeoniae Rubra 7-11% Radix Curcumae 6-10%
Rhizoma Dioscoreae Septemlobae 5-9% Radix Rehmanniae 10-15%
Radix Paeoniae Alba 6-9%.
The present invention compared with prior art, it is the medicine of being made by pure Chinese herbal medicine, have no side effect, cure rate height, but heat-clearing and toxic substances removing, anti-inflammation and sterilization, resolving turbidity and eliminating dampness, blood circulation promoting and blood stasis dispelling, the liver and the kidney tonifying is a kind of active drug for the treatment of chronic bacterial prostatitis.
Further specify the present invention below in conjunction with embodiment
Embodiment
One, be purchased and the pure Chinese herbal medicine of the following weight of weighing:
Flos Lonicerae 3.0Kg Herba Violae 3.0Kg
Give birth to Radix Glycyrrhizae 1.5Kg Rhizoma Anemarrhenae 2.0Kg
Cortex Phellodendri 2.0Kg Radix Angelicae Sinensis 2.0Kg
Radix Salviae Miltiorrhizae 2.0Kg Radix Dipsaci 2.0Kg
Radix Paeoniae Rubra 2.0Kg Radix Curcumae 2.0Kg
Rhizoma Dioscoreae Septemlobae 1.5Kg Radix Rehmanniae 4.0Kg
Radix Paeoniae Alba 2.0Kg
Said herbal medicine is ground, cross 120 mesh sieves, mix,, dress up the medicine that the present invention of 72500 treats chronic bacterial prostatitis altogether with every dress of capsule fill 0.4g, must health before having another name called.

Claims (1)

1, a kind of medicine for the treatment of chronic bacterial prostatitis, it is a principal agent by Flos Lonicerae, Herba Violae, living Radix Glycyrrhizae, the Rhizoma Anemarrhenae, Cortex Phellodendri mainly, pair is prepared from pure Chinese herbal medicine such as Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Radix Dipsaci, Radix Paeoniae Rubra, Radix Curcumae, Radix Rehmanniae, the Radix Paeoniae Albas, and it is characterized in that: it is the medicine that is prepared from by following weight percentages:
Flos Lonicerae 8-12% Herba Violae 8-12%
Give birth to Radix Glycyrrhizae 5-7% Rhizoma Anemarrhenae 6-10%
Cortex Phellodendri 6-10% Radix Angelicae Sinensis 6-9%
Radix Salviae Miltiorrhizae 7-12% Radix Dipsaci 6-10%
Radix Paeoniae Rubra 7-11% Radix Curcumae 6-10%
Rhizoma Dioscoreae Septemlobae 5-9% Radix Rehmanniae 10-15%
Radix Paeoniae Alba 6-9%.
CN 98123563 1998-11-02 1998-11-02 Medicine for curing chronic bacterial prostatitis Pending CN1219421A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 98123563 CN1219421A (en) 1998-11-02 1998-11-02 Medicine for curing chronic bacterial prostatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 98123563 CN1219421A (en) 1998-11-02 1998-11-02 Medicine for curing chronic bacterial prostatitis

Publications (1)

Publication Number Publication Date
CN1219421A true CN1219421A (en) 1999-06-16

Family

ID=5228245

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 98123563 Pending CN1219421A (en) 1998-11-02 1998-11-02 Medicine for curing chronic bacterial prostatitis

Country Status (1)

Country Link
CN (1) CN1219421A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062681A1 (en) * 2003-01-16 2004-07-29 Healthaid Enterprise Pte. Ltd. Herbal compositions for prostate conditions
CN101623457B (en) * 2009-07-31 2011-06-29 程立法 Traditional Chinese medicine for treating chronic prostatitis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062681A1 (en) * 2003-01-16 2004-07-29 Healthaid Enterprise Pte. Ltd. Herbal compositions for prostate conditions
AU2004204574B2 (en) * 2003-01-16 2008-07-17 Healthaid Enterprise Pte. Ltd. Herbal compositions for prostate conditions
CN101623457B (en) * 2009-07-31 2011-06-29 程立法 Traditional Chinese medicine for treating chronic prostatitis

Similar Documents

Publication Publication Date Title
CN1151806C (en) Capsule for curing cholecystitis
CN1204523A (en) Prescription of dispelling wind and strengthening bone wine and preparation method
CN112891399A (en) Traditional Chinese medicine composition and application and preparation method thereof
CN103638370A (en) Traditional Chinese medicine for treating dental ulcer
CN102100872A (en) Chinese medicine preparation for treating mastitis
CN1278446A (en) Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease
CN101129675B (en) Externally used plaster for treating rheumatism and kind of rheumatism
CN1172690C (en) Chinese medicine powder for treating tetanic rachitis
CN101810737A (en) Chinese medicinal preparation for treating pelvic inflammation
CN1074294C (en) Process for making medical wine for treating rheumatism
CN1260984A (en) Exterior-applied Chinese medicine for treating trauma
CN101062397A (en) Angelica sinensis liquor for treating frostbite
CN1036699A (en) " skin medicine " liquid medicine compound method
CN1351872A (en) Chinese herbal medicine for curing comedo and acne
CN1219421A (en) Medicine for curing chronic bacterial prostatitis
CN1169535C (en) Chinese medicine for treating hepatitis B
CN1136907C (en) Making process of enzyme degrading oral liquid
CN1298376C (en) Pure Chinese medicine capsule for treating psora and its preparation technology
CN101658652A (en) Chinese medicinal preparation for treating chronic appendicitis
CN104248691A (en) Medicament for the treatment of prurigo nodularis
CN110585300A (en) Medicine for treating arthralgia-synadrome and preparation method thereof
CN1060076C (en) Gucixiao pill for removing spur
CN1186083C (en) Chinese medicine for treating mammary gland foliole proliferation
CN1298724A (en) Medicine for treating immunodefiiciency disease
CN103656537A (en) Traditional Chinese medicine for treating pneumonia

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication